Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amygdala and Insula Retraining (AIR) Program and HUS Internet Therapy Compared to Treatment as Usual in Bodily Stress Syndrome, Fibromyalgia, Post Covid-19, and Chronic Fatigue Syndrome (ME/CFS)

NCT05212467 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT05212467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05212467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amygdala and Insula Retraining (AIR) Program and HUS Internet Therapy Compared to Treatment as Usual in Bodily Stress Syndrome, Fibromyalgia, Post Covid-19, and Chronic Fatigue Syndrome (ME/CFS)
Lead sponsor
Helsinki University Central Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2022
Completion date
December 31, 2024
Enrollment
360 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

functional disorders, post covid-19